Precigen, Inc.
Precigen, Inc., a pioneering biotechnology company headquartered in the United States, focuses on advancing gene and cell therapies to address significant unmet medical needs. Founded in 2013, Precigen has rapidly established itself in the biopharmaceutical industry, particularly in the fields of immuno-oncology and genetic medicine. The company is renowned for its innovative platforms, including UltraCAR-T™ and AdenoVerse™, which enable the development of unique therapies designed to enhance patient outcomes. With a commitment to transforming healthcare, Precigen has achieved notable milestones, including strategic partnerships and advancements in clinical trials. Positioned as a leader in the biotechnology sector, Precigen continues to push the boundaries of science, striving to deliver cutting-edge solutions that redefine treatment paradigms and improve the lives of patients worldwide.
DitchCarbon Score
How does Precigen, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Precigen, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Precigen, Inc.'s reported carbon emissions
Precigen, Inc., headquartered in the US, currently does not report any carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any specific reduction targets or climate pledges. As such, there are no significant achievements or commitments to highlight regarding their carbon footprint or climate initiatives. In the absence of reported emissions data and reduction initiatives, it is important to note that many companies in the biotechnology sector are increasingly focusing on sustainability and climate commitments. This trend often includes setting science-based targets and participating in global initiatives aimed at reducing greenhouse gas emissions. However, without specific data or commitments from Precigen, Inc., it is challenging to provide a detailed overview of their climate strategy or performance.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Precigen, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
